Crinetics Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2021 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Crinetics Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q2 2024.
  • Crinetics Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 79M shares, a 45.6% increase year-over-year.
  • Crinetics Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 58.1M shares, a 11.7% increase from 2022.
  • Crinetics Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 52M shares, a 35.2% increase from 2021.
  • Crinetics Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 38.4M shares, a 26.2% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 79M +24.7M +45.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 72.3M +18.4M +34.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 58.1M +6.09M +11.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 56.8M +3.04M +5.65% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 54.3M +1.75M +3.34% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 53.9M +6.2M +13% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 52M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 53.8M +15.5M +40.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 52.5M +15.5M +41.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 47.7M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q3 2021 38.3M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 37.1M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.